16 January 2023 - The Scottish Medicines Consortium, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on three new medicines.

Mobocertinib succinate (Exkivity) was accepted for the treatment of adults with locally advanced or metastatic non-small cell lung cancer who have received prior chemotherapy.

Read SMC press release